Current Prices from NeOnc Technologies Holdings, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	NTHI	USD	25.07.2025 21:43	5,05 USD	0,21 USD +4,34 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	12,65 %	26,25 %	-32,21 %	-32,49 %	-32,49 %	-32,49 %

Company Profile for NeOnc Technologies Holdings, Inc. - Common Stock Share

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Company Data

Name NeOnc Technologies Holdings, Inc. - Common Stock

Company Neonc Technologies Holdings, Inc.

Symbol NTHI

Website https://www.neonctech.com

Primary Exchange

NASDAQ

ISIN US64051A1016

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. Thomas C. Chen M.D., Ph.D.

Market Capitalization 142 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 8335 Sunset Boulevard, 90069 Calabasas

IPO Date 2025-03-26

Ticker Symbols

Name	Symbol
NASDAQ	NTHI

More Shares

Investors who NeOnc Technologies Holdings, Inc. - Common Stock hold also have the following shares in their portfolio:

DDC Enterprise Limited Class A Ordinary Shares Share

Kaival Brands Innovations Group, Inc. - Common Stock Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog